A Scalable Approach Reveals Functional Responses of iPSC Cardiomyocyte 3D Spheroids

Matthew P Burnham1,2, Rachel Harvey3, Rebecca Sargeant4

  • 1Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Alderley Park, UK.

Summary

We developed a scalable, label-free 96-well plate system for 3D induced pluripotent stem cell-derived cardiomyocyte (iPSC-CM) spheroids. This method accurately measures contractility and electrical activity, improving cardiovascular drug discovery assays.

Related Concept Videos